• Japanese
  • Korean
  • Chinese
Cover Image

Pharmaceutical Packaging 2012 to 2016

Abstract

"Pharmaceutical Packaging 2012 to 2016" examines the global pharmaceutical packaging industry, an important partner with the pharmaceutical industry, one of the worldxs most important, powerful, and sophisticated industries. This comprehensive Study analyzes markets, technologies, and opportunities for drug packaging, and presents their global ramifications as an aid to effective decision-making and strategy development.

The Study identifies and tracks the trajectory of market-driving forces from around the world, including the expected impacts on global drug packaging from:

  • new drug product development
  • consumer needs and expectations
  • geographic influences
  • governmental regulations
  • packaging for OTC vs. ethical products
  • packaging innovations

The Study's in-depth analyses of these factors help generate Global Growth Forecasts that will be of keen interest to decision-makers who are engaged with pharmaceutical packaging. For example, quantitative forecasts are included for packaging types (primary and secondary) and materials, packaging consumed within multiple geographic regions, and the growth of package design solutions to provide functionality for patient compliance, anti-counterfeiting, child-resistance or tamper evidence.

Table of Contents

Section I:

Introduction

  • A. Pharmaceuticals defined
  • B. Pharmaceutical packaging defined
  • C. Study organization
  • D. Methodology
  • E. Geographic regions
  • F. Conventions

Section II:

Executive Summary

  • A. Drivers and trends
    • 1. Consumer needs
    • 2. Healthcare system costs
    • 3. Biologics
    • 4. Generic and over-the-counter (OTC) markets
    • 5. Drug delivery methods
    • 6. Child resistance
    • 7. Anti-counterfeiting
    • 8. Tamper evidence
    • 9. Patient compliance
  • B. Market projections
    • 1. Global primary packaging volume by drug delivery method
    • 2. Global primary packaging volume by package type
    • 3. Global primary packaging value segmented by package type
    • 4. Global secondary packaging volume segmented by package type
    • 5. Global secondary packaging value segmented by package type
    • 6. Global primary packaging volume by geographic region
    • 7. Global primary packaging volume segmented by regulatory status
    • 8. Global primary packaging volume by drug production process
    • 9. Global primary packaging volume by distribution channel
    • 10. Global primary packaging volume by patient compliance
    • 11. Global primary packaging volume by anti-counterfeit solutions
    • 12. Global primary packaging volume by child-resistance

Section III:

Technology

  • A. Technology priorities
    • 1. Drug safety and efficacy
    • 2. Drug sensitivity
    • 3. Drug delivery method
    • 4. Regulations - drug safety and efficacy
    • 5. Packaging cost
    • 6. Environment and health
    • 7. Packaging requirements
  • B. Devices versus packages
    • 1. Inhalers
    • 2. Pen injection systems
    • 3. Auto-injectors
  • C. Primary packaging
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. Intravenous (IV) bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other primary containers
    • 13. Innerseals
    • 14. Closures
  • D. Secondary packaging
    • 1. Folding cartons
    • 2. Blister cards and wallets
    • 3. Shrink bands
    • 4. Labels
    • 5. Other
  • E. Compliance packaging
  • F. Child-resistant packaging
    • 1. Multi-dose packaging
    • 2. Unit-dose packaging
    • 3. Additional child-resistant technologies
  • G. Tamper-evident packaging
  • H. Unit-dose packaging
  • I. Anti-counterfeit packaging
    • 1. Overt solutions
    • 2. Covert solutions
    • 3. Summary
  • J. Labelling
  • K. Identification and tracking
    • 1. Barcodes
    • 2. Radio frequency identification (RFID)
  • L. Active packaging
  • M. Packaging processes for sterile drugs
    • 1. Traditional aseptic packaging
    • 2. Aseptic packaging with barrier isolation technology
    • 3. Terminal sterilization (in-package sterilization)
  • N. Packaging processes for non-sterile drugs
  • O. Pharmaceutical packaging materials
    • 1. Polymers
    • 2. Glass
    • 3. Aluminum foil
    • 4. Paper
    • 5. Paperboard
    • 6. Other
  • P. Packaging structures
    • 1. Blister pack structures
    • 2. Bottles, vials, ampules, cartridges, and mini-jars
    • 3. Pouch structures
    • 4. Pre-filled syringes
    • 5. IV bags
    • 6. Tube structures
    • 7. Secondary packaging
    • 8. Other structures
  • Q. Pharmaceutical packaging equipment technology
    • 1. Filling equipment
    • 2. Filling equipment suppliers

Section IV:

Market Trends and Projections

  • A. Pharmaceutical industry drivers and trends
    • 1. Government policies
    • 2. Macro environment
    • 3. New drugs
    • 4. New drug delivery techniques
    • 5. Biologics
    • 6. Generic drugs
    • 7. Delivery devices
    • 8. New drug production techniques
  • B. Pharmaceutical packaging industry drivers and trends
    • 1. Underlying product trends
    • 2. Regulatory environment
    • 3. Government healthcare programs
    • 4. Product differentiation
    • 5. Drug safety
    • 6. Conversions from prescription to OTC
    • 7. Alternative drug delivery methods
    • 8. Environmental
    • 9. Drug protection requirements
  • C. Global primary packaging volume by delivery method
    • 1. Cutaneous
    • 2. Inhaled
    • 3. Nasal
    • 4. Ocular
    • 5. Oral delivery
    • 6. Parenteral
    • 7. Transdermal
    • 8. Other
  • D. Global primary packaging volume by package type
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. IV bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other
    • 13. Closures
    • 14. Fitments
    • 15. Innerseals
    • 16. Valves
  • E. Global primary packaging value segmented by package type
  • F. BRIC primary packaging volume by packaging type
  • G. Europe primary packaging volume by packaging type
  • H. Japan primary packaging volume by packaging type
  • I. North America primary packaging volume by package type
  • J. ROW primary packaging volume by packaging type
  • K. Global primary packaging volume by geographic region
    • 1. BRIC
    • 2. Europe
    • 3. Japan
    • 4. North America
    • 5. Rest of World (ROW)
    • L. Global primary packaging value by geographic region
  • M. Global secondary packaging volume by package type
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • N. Global secondary packaging value by package type
  • O. Primary packaging volume segmented by regulatory status
    • 1. Over-the-counter pharmaceuticals
    • 2. Prescription
    • 3. Projection
  • P. Primary packaging volume by drug production process
    • 1. Chemical
    • 2. Biological
    • 3. Projection
  • Q. Primary packaging volume by distribution channel
    • 1. Institutional
    • 2. Retail
    • 3. Projection
  • R. Primary packaging volume segmented by compliance features
    • 1. Compliance
    • 2. Projection
  • S. Primary packaging volume segmented by anti-counterfeiting
    • 1. Anti-counterfeit
    • 2. Projection
  • T. Primary packaging volume by child resistance
    • 1. Child resistance
    • 2. Projection
  • U. Primary packaging volume by tamper evidence
    • 1. Tamper evidence
    • 2. Projection
  • V. Primary packaging volume segmented by material type
    • 1. Primary packaging
    • 2. Blister pack
    • 3. Tubes
    • 4. Pouches and strip packs
    • 5. Secondary packaging

Section V:

  • Packaging Producers

Section VI:

  • Equipment Suppliers

Section VII:

  • Glossary
Show More
Pricing
Get Notified
Email me when related reports are published